The Venture Codex Logo

The Venture Codex

Biovance Capital

Rua do Mar Vermelho 2, office 2.1, Lisboa, 1990-152, Portugal

Overview

Investment fund for early-stage biotech companies developing therapeutics.

Founded

2024

Deals · 12mo

2

Links

WebsiteLinkedIn

Stage focus

Seed
Series A

Geographic focus

Spain
The Netherlands

Sector focus

Biotechnology

Investment portfolio

2rounds
NAMEDATESIZE
Vaxdyn
Sep 2026Led
$13 MSeries A
Laigo Bio
Mar 2026Led
$19 MSeed
Vaxdyn
Sep 2026Led
$13 MSeries A
Laigo Bio
Mar 2026Led
$19 MSeed
2
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Biovance Capital: 2 funding rounds are recorded in the selected participation categories.All available history.
Biovance Capital: 2 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Seed10
Series A10

Monthly Deal Activity

Biovance Capital: 2 deals are recorded across 8 months.All available history.
Biovance Capital: 2 deals are recorded across 8 months. All available history
MonthDeals
Mar '261
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '261
Oct '260

Sector Breakdown

Biovance Capital: Health & Life Sciences is the largest displayed sector by deal count (2 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Biovance Capital: Health & Life Sciences is the largest displayed sector by deal count (2 deals). All available history
SectorDeals
Health & Life Sciences2

Deal Size Distribution

Biovance Capital: 2 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Biovance Capital: 2 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M0
$10M-$25M2
$25M-$50M0
$50M-$100M0
$100M-$250M0
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Biovance Capital: Europe has the largest recorded deal count among the displayed regions (2 deals).All available history.

Top 1 of 1 regions; European countries are grouped as Europe.

Biovance Capital: Europe has the largest recorded deal count among the displayed regions (2 deals). All available history
RegionDeals
Europe2
Biovance Capital: 11 co-investors are shown, with Angelini Ventures sharing 1 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Biovance Capital: 11 co-investors are shown, with Angelini Ventures sharing 1 recorded deals. All available history
Co-investorShared deals
Angelini Ventures1
Arcano Partners1
ArgoBio1
Cancer Research Horizons1
Curie Capital1
EIC Fund1
Eurazeo1
Impacto Andalucía Innovación y Desarrollo1
Kurma Partners1
Oncode Oncology Bridge Fund1
ROM Utrecht Region1

Investment Strategy

Biovance Capital: Led accounts for 100% and participating for 0% of round participation.All available history.
Biovance Capital: Led accounts for 100% and participating for 0% of round participation. All available history
CategoryDeals (count)Share (%)
Led2100%
Participating00%
Biovance Capital: Single-lead accounts for 50% and co-led for 50% of lead dynamics.All available history.
Biovance Capital: Single-lead accounts for 50% and co-led for 50% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead150%
Co-led150%

Team

André Albergaria
Joao Incio, MD PhD

General Partner

Ricardo Perdigão Henriques, PhD

Managing Partner